首页> 外文期刊>JAMA dermatology >Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy
【24h】

Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy

机译:通过体内共聚焦显微镜定位改善恶性程度高的管理和患者护理

获取原文
获取原文并翻译 | 示例
       

摘要

Importance: Lentigo maligna (LM) is a clinical, pathologic, and therapeutic challenge with a higher risk of local recurrence than other types of melanoma correctly treated and also carries the cosmetically sensitive localization of head and neck. Objective: To determine whether in vivo reflectance confocal microscopy (RCM) mapping of difficult LM cases might alter patient care and management. Design: Analysis of LM and LM melanoma (LMM) in a series of patients with large facial lesions requiring complex reconstructive surgery and/or recurrent or poorly delineated lesions at any body sites were investigated. Settings: Two tertiary referral melanoma centers in Sydney, Australia. Participants: Thirty-seven patients with LM (including 5 with LMM) were mapped with RCM. Fifteen patients had a recurrent LM, including 9with multiple prior recurrences. The LM was classified amelanotic in 10 patients, lightly pigmented in 9, and partially pigmented in 18. Interventions: The RCM images were obtained in 4 radial directions (allowing for anatomic barriers) for LM margin delineation using an RCM LM score previously described by our research team. Main Outcome Measures: Differences in the margin of LM as determined by RCM vs dermoscopy vs histopathologic analysis. Results: Seventeen of 29 patients (59%) with dermoscopically visible lesions had subclinical (RCMidentified) disease evident more than 5 mm beyond the dermoscopy margin (ie, beyond the excision margin recommended in published guidelines). The RCM mapping changed the management in 27 patients (73%): 11 patients had a major change in their surgical procedure, and 16 were offered radiotherapy or imiquimod treatment as a consequence of the RCM findings. Treatment was surgical in 17 of 37 patients. Surgical excision margins (based on the RCM mapping) were histopathologically involved in only 2 patients, each of whom had an LM lesion larger than 6 cm. Conclusions and Relevance: In vivo RCM can provide valuable information facilitating optimal patient care management.
机译:重要性:恶性肿瘤(LM)是临床,病理和治疗方面的挑战,与正确治疗的其他类型黑素瘤相比,它具有更高的局部复发风险,并且还具有头颈部美容敏感的定位。目的:确定难治性LM病例的体内反射共聚焦显微镜(RCM)作图是否可能改变患者的护理和管理。设计:对一系列面部病变较大,需要复杂的重建手术和/或在任何身体部位复发或轮廓不清的病变的患者进行的LM和LM黑色素瘤(LMM)分析进行了研究。地点:澳大利亚悉尼的两个三级转诊黑色素瘤中心。参与者:37例LM患者(包括5例LMM)接受了RCM定位。 15例患者患有LM复发,其中9例患者多次复发。 LM在10例患者中被分类为类风湿性关节炎,9例为浅色素,18例为局部色素。研究小组。主要结果指标:通过RCM,皮肤镜检查,组织病理学分析确定的LM边缘差异。结果:29例在皮肤镜下可见病变的患者中有17例(59%)患有亚临床(RCMidentified)疾病,明显超出皮肤镜检查界限(即已发布指南中建议的切除界限)超过5毫米。 RCM测绘改变了27例患者的治疗方法(73%):11例患者的手术程序发生了重大变化,由于RCM的发现,对16例患者进行了放疗或咪喹莫特治疗。 37例患者中有17例是手术治疗。手术切除切缘(基于RCM映射)在组织病理学上仅涉及2位患者,每位患者的LM病变均大于6厘米。结论和相关性:体内RCM可以提供有价值的信息,促进最佳的患者护理管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号